All Stories

  1. ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions
  2. Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience
  3. Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru
  4. Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: The ProVac experience
  5. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination
  6. Indicators to assess National Immunization Technical Advisory Groups (NITAGs)
  7. Vaccination legislation in Latin America and the Caribbean
  8. Performing Country-led Economic Evaluations to Inform Immunization Policy: ProVac Experiences in Latin America and the Caribbean
  9. Monitoring of progress in the establishment and strengthening of national immunization technical advisory groups
  10. Yellow Fever and Health Diplomacy: International Efforts to Stop the Urban Yellow Fever Outbreak in Paraguay
  11. Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina
  12. Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: Lessons learned by PAHO's ProVac Initiative
  13. Immunization policy decisions
  14. Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries